Category: UK

Posted on

CV #30(B): Pfizer Still Lobbying In Canada, Vaccine Approved In U.K.

Vaccines are coming into Canada from Pfizer and others. This was recently been announced on the CBC. For some context, remember that:
-The virus survival rate is over 99% (if it even exists)
-PCR tests are useless as diagnostic tools (again, if it even exists)
-People have to be tested to know they have it
-Vaccines were cooked up in the last few months, side effects unknown
-Things like masks will continue afterwards

1. Rempel Isn’t Who She Pretends To Be

In the video with Michelle Rempel-Garner (discussing Derek Sloan’s petition), it’s interesting that she shrugs off the very valid concerns of unproven drugs. She also doesn’t question the wisdom behind lockdowns themselves. Want your freedom? Shut up and get the vaccine. This is typical of “conservative” politicians in Canada.

Rempel isn’t who she appears to be. And why exactly does she keep looking to her right in the video? Is there someone else in the room?

2. Pfizer Lobbying Ottawa Regularly

Pfizer has lobbied the Federal Government 153 times since becoming a registered lobbyist in 2007. Of course, that doesn’t include any discussions that may be “off the books”. One of Pfizer’s lobbyists, Steven Hogue, used to work in the Prime Minister’s Office when Jean Chretien was in office.

3. Goldy Hyer Ex-Pfizer Lobbyist In Ottawa

Goldy Hyer was at a time the Chief-of-Staff for Joe Clark, then Leader of the Progressive Conservative Party of Canada. He is also involved with:
(a) The Century Initiative
(b) Asia Business Leaders Advisory Council
(c) Catalyst Inc. / Catalyst Canada
(d) 30% Club Canada

4. Pfizer Lobbied M-132 Committee Vice-Chairs

Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.

M-132 was filed in late 2017, by Raj Saini. It was a motion to finance pharmaceuticals, and pharmaceutical research, both in Canada and abroad. See here and here. Marilyn Gladue, and Don Davies, (both lobbied by Pfizer), were the Vice-Chairs on that Committee.

5. Pfizer Lobbying In Ontario

Pfizer has also been busy lobbying Ontario since 2002 over pharmaceutical interests. It’s worth noting, that both Kathleen Wynne and Doug Ford never fully implemented Bill 160. This Bill would have mandated disclosure, (rather than it being optional), of payments made to health care providers to sell certain drugs.

Since Bill 160 isn’t really the law, there’s no requirement hospitals or health care staff to disclose the financing they may get to push certain remedies.

8. Pfizer Lobbying In Manitoba

Manitoba has had lobbyists from Pfizer in the past, but none active since 2017. Perhaps they have moved on to Ottawa.

7. Pfizer Lobbying In Alberta

A search in the Alberta Lobbyist Registry shows 12 meetings since 2018 between Government officials, and Pfizer. The last one was just the other day. Jason Kenney isn’t doing quite the “hard sell” that Ford does, but he is still fully on board with the agenda.

Of course, there is other lobbying going on, and in other Provinces as well. These examples provided are hardly exhaustive of what’s going on, but should provide a decent sample.

8. Hajdu Order To Approve Untested Vaccines

Interim Orders
Marginal note:Interim orders
.
30.1 (1) The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment.
.
Marginal note: Cessation of effect
.
(2) An interim order has effect from the time that it is made but ceases to have effect on the earliest of
.
(a) 14 days after it is made, unless it is approved by the Governor in Council,
.
(b) the day on which it is repealed,
.
(c) the day on which a regulation made under this Act, that has the same effect as the interim order, comes into force, and
.
(d) one year after the interim order is made or any shorter period that may be specified in the interim order.

On September 16, 2020, Health Minister Patty Hajdu signed an Interim Order allowing for approval of vaccines in an expedited manner, even if they were fully tested. Section 30.1 of the Food and Drug Act allows that. It must be pointed out, however, that Hajdu is not a doctor, and has no medical background at all.

9. UK Approves Pfizer/BioNTech Vaccine, Dec. 2

Tens of thousands of people will receive an effective and high-quality COVID-19 vaccine from next week, as the UK becomes the first country in the western world to authorise a vaccine.

Following rigorous clinical trials involving thousands of people and extensive analysis of the vaccine’s safety, quality and effectiveness by experts from the Medicines and Healthcare products Regulatory Agency (MHRA), Pfizer/BioNTech’s vaccine has been authorised for use in the UK.

Now authorisation has been granted, Pfizer will deliver the vaccine to the UK. In making the recommendation to authorise supply, the MHRA will decide what additional quality assurance checks may be required before a vaccine can be made available. Pfizer will then deliver the vaccines to the UK as soon as possible.

The NHS has decades of experience in rolling out successful widespread vaccination programmes and has put in place extensive deployment plans.

In line with the recommendations of the independent Joint Committee for Vaccination and Immunisation (JCVI), the vaccine will be rolled out to the priority groups including care home residents and staff, people over 80 and health and care workers, then to the rest of the population in order of age and risk, including those who are clinically extremely vulnerable.

Isn’t this great? Pfizer/BioNTech got their approval to start distributing vaccines in the UK. Surely, with all these rigorous tests, they are certain that the product is safe, right?

10. UK: Vaccine Damage Payments Scheme

In advance of a rollout of an authorised COVID-19 vaccine and in line with other immunisation programmes, the government is taking the precautionary step to ensure that, in the very rare possibility where someone is severely disabled as a result of taking a COVID-19 vaccine, they can access financial assistance through the Vaccine Damage Payments Scheme (VDPS).

No safety concerns have been reported in vaccines authorised for use following rigorous clinical trials involving tens of thousands of people and extensive analysis of the vaccine’s safety, quality and effectiveness by experts from the Medicines and Healthcare products Regulatory Agency (MHRA).

Pfizer/BioNTech’s vaccine is now the first COVID-19 vaccine to be authorised for use in the UK, and the MHRA will keep safety under continual review.

Adding diseases to the VDPS is not new and numerous diseases have been added as successive governments have rolled out more immunisation programmes, such as HPV and Meningitis B. In response to the H1N1 (swine flu) pandemic, the previous government added swine flu to the VDPS on 10 October 2009.

Generally, only those who were administered vaccines as part of a childhood immunisation programme are covered under the VDPS. However, because COVID-19 vaccines will be rolled out to a large proportion of the adult population, the government will amend the eligibility requirements, ensuring adults who are administered a COVID-19 vaccine in the UK or Isle of Man, or as part of an armed forces medical treatment, will be covered by the scheme too.

The VDPS is a safety net to help ease the burden on individuals who have in extremely rare circumstances experienced harm due to receiving a government-recommended vaccine. It is not a compensation scheme. Rather, it provides a one-off, tax-free lump sum – currently £120,000 – for those suffering a severe disability as a result of a vaccine against a disease listed under the Vaccine Damage Payments Act.

Background information
Currently, in order to qualify for the payment, it must be accepted, on the balance of probability, that there is a causal link between the vaccine and the claimed disability and that the resulting disability amounts to severe (ie at least 60%) disablement.
.
Claims are assessed and paid where successful by the Department for Work and Pensions.

The UK Government only the day before announces approval for Pfizer/BioNTech’s vaccine. Almost immediately afterwards, the UK reveals that taxpayers will be on the hook for any injuries that result from these vaccines.

The amount is capped at £120,000, and even then, it’s only with very serious disability. Capitalized profits, socialized compensation. Of course, the implication of having a vaccine compensation scheme means that the companies themselves will be off the hook for whatever death and injury results.

11. Pfizer And Violation Tracker

Of course, Pfizer isn’t too willing to share some of it’s more troubling history, such as this provided by Violation Tracker. Well worth a long read. Everything from false claims, to bribery, to kickbacks are cited.

12. Gates A Recent Pfizer Donor

In addition to making contributions to Pfizer, the Bill & Melinda Gates Foundation owns over $1.7 million in stock from the pharmaceutical company.

BILL & MELINDA GATES FOUNDATION
EIN: 56-2618866
gates.foundation.taxes.2016
gates.foundation.taxes.2017
gates.foundation.taxes.2018

BILL & MELINDA GATES FOUNDATION TRUST
EIN: 91-1663695
gates.foundation.trust.taxes.2018

Take a look at the documents for yourself. The full list can be found here, just search for the Bill & Melinda Gates Foundation. Those 2 organizations will pop up.

The above screenshots are donations the Gates Foundation made in 2016 and 2018.

13. Pfizer Vaccines Coming To Canada/U.S.

Pfizer has already applied for permission to begin distributing in Canada and the United States, and they very likely will get it. If it’s anything like what happened with GlaxoSmithKline, they’ll be indemnified as well. Even if Canada were to set up a compensation scheme, it will never fully make up for the harm done.

And this point is critical: the vaccines haven’t even been fully tested. They’ll be doing more long term studies as the years go on. This is not the same thing as having vaccines ready.

As Tam says: vaccines normally take a decade or more. But here, just a few months apparently. And all for something with a mortality rate approximately that of the flu.

What about long term problems like premature death? Sterilization? Paralysis? Pain? Disfiguration? Unfortunately, a lot of that won’t become clear for a few years at least. Consequently, people will have to hope and pray.

Pfizer’s Vaccine Promoted On CBC News
Lobbying Commissioner’s Office In Canada
Lobbying Registry Of Ontario
Manitoba Provincial Lobbying Registry
Alberta Lobbyist Registry
Pfizer Lobbying The Federal Government On Vaccines
Goldy Hyer Ex-Pfizer Lobbyist In Ottawa
Goldy Hyer’s LinkedIn Page
M-132, Parliamentary Study On International Vaccines
Section 30.1 Of Canada Food And Drug Act
Interim Order Allowing CV Vaccines To Be Sold In Canada

UK To Allow Certain Vaccines Deployed In Country
https://archive.is/wTXun
CV-19 To Be Added To UK Vaccine Compensation Scheme
https://archive.is/fHGKZ

GSK Indemnified Against Damages For H1N1 Vaccines In 2009
Pfizer Clinical Information
Pfizer And Violation Tracker Documentation

Posted on

CV #35(B): Deja Vu? Parallels With 2009 H1N1; Ferguson; PCR; Limited Trials; Indemnification

“The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment.” Section 30.1(1) of the Food and Drugs Act. Sure, there are standards, but they can be bypassed if needed.

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes, obscuring the vile agenda called the “Great Reset“. The Gates Foundation finances: the WHO, the US CDC, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the BBC, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here. The media is paid off, and our democracy compromised, shown: here, here, here, and here.

2. Important Links

Imperial College London Modelling H1N1
https://archive.is/KLgV2
Imperial College London’s Findings On Swine Flu (H1N1)
https://archive.is/gj4R6
CDC Approves PCR Tests For H1N1 Detection
Interim Order Allowing H1N1 Vaccine
[A] Q&A About Vaccine Arepanrix H1N1 Approval
[A] Information About Research Performed
https://archive.is/WskgA
[B] Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine
https://archive.is/wip/q1Z79
Food & Drug Act Of Canada
Adam v. GlaxoSmithKline Inc., 2019 ONSC 7066 (CanLII)
2010 Film: Outbreak, Anatomy Of A Plague
Rockefeller.Foundation.lockstep.2010

Order In Council: 2009-1769
Order In Council: 2009-1857

3. Neil Ferguson’s Shoddy Modelling

Neil Ferguson and Imperial College London were also involved in modelling H1N1 (Swine Flu), over a decade ago. His models are about as off the mark then as they are now.

Imperial College London has financial ties to the Bill & Melinda Gates Foundation. Gates himself shows interest in many of ICL’s activities.

Professor Neil Ferguson, the corresponding author of the new research from the MRC Centre for Outbreak Analysis and Modelling at Imperial College London, said: “Our study shows that this virus is spreading just as we would expect for the early stages of a flu pandemic. So far, it has been following a very similar pattern to the flu pandemic in 1957, in terms of the proportion of people who are becoming infected and the percentage of potentially fatal cases that we are seeing.

“What we’re seeing is not the same as seasonal flu and there is still cause for concern – we would expect this pandemic to at least double the burden on our healthcare systems. However, this initial modelling suggests that the H1N1 virus is not as easily transmitted or as lethal as that found in the flu pandemic in 1918,” added Professor Ferguson.

Even back in 2009 (and in fact earlier), Ferguson was quite willing to push the panic button based on very incomplete information. It must be noted that models are not proof or evidence, they are merely predictions. These predictions are subjected to the same limitations and biases of the people conducting them.

Ferguson’s “models” predicted some 65,000 deaths in the U.K. as a result of Swine Flu. A total of 457 materialized in the end. And it’s just one of the times he’s grossly overshot the mark.

4. PCR Tests Used For Swine Flu Detection

This guidance was revised to clarify that the current rRT-PCR developed by CDC to detect novel influenza A ( H1N1) is authorized by the FDA. The FDA authorization, also termed Emergency Use Authorization or EUA, is not equivalent to FDA cleared, which was incorrectly stated in the previous version of the guidance.

Those PCR tests (which don’t detect Covid-19), were also approved for use in diagnosing H1N1 by the Center for Disease Control in the U.S. The technology wasn’t suited then, and isn’t now.

5. Inadequate Clinical Trials: (Arepanrix H1N1)

4. What evidence was used to support the authorization of Arepanrix™ H1N1?
A prototype or “mock” vaccine was developed in the pre-pandemic period using another strain of influenza virus, the H5N1 strain. During this period Health Canada inspected the vaccine manufacturing facilities, validated the vaccine production process, and reviewed results from both animal and human studies with the mock vaccine. In addition, the safety and effectiveness of the adjuvant to be used with the vaccine was assessed by Health Canada. Once the H1N1 virus emerged as the pandemic virus, the manufacturer initiated vaccine production using the strain recommended by the WHO.

5. What are the benefits and potential risks associated with Arepanrix™ H1N1?
Criteria have been established to assess the immunogenicity of vaccines. Clinical trial results indicate that Arepanrix meets all of these criteria, which means that the vaccine produces an adequate level of protection against the H1N1 pandemic virus.
.
As with all medicinal products, there may be side effects or adverse events associated with the use of the product. Some of the very common adverse events that have been observed in clinical trials with the pandemic vaccine include pain at the injection site, fatigue, headache, swollen glands in the neck, joint pain, and muscle ache. Refer to the product leaflet for additional information on adverse events.

6. How was Arepanrix™ H1N1 authorized?
Arepanrix™ H1N1 was approved because it was shown that the benefits of the vaccine outweigh any risks. The time frame between vaccine manufacturing and the need to use the vaccine in time to provide the public with protection against the virus is very short. As a result, it has not been possible for the manufacturer to collect the usual full information necessary for a Notice of Compliance to be issued under the Food and Drug Regulations. For this reason, an Interim Order was used to provide an alternate pathway to allow for the authorization for sale of the vaccine. Under the Interim Order, the manufacturer is required to continue submitting data on the safety and effectiveness of the vaccine. Health Canada and the Public Health Agency of Canada will review this information as it becomes available.

This vaccine was rushed out for use in the general population. This was despite the testing not being complete. The Minister of Health signed an interim Order allowing it to be dispensed anyway.

It’s worth pointing out that initial trials were not even conducted on the H1N1 influenza strain, but on another one. Fair to ask how valid that initial research would be.

Elderly (>60 years):
There are limited data available from clinical studies with Pandemrix™ (H1N1) and with Arepanrix™ H1N1 vaccine in adults aged over 60 years.
.
The recommended dosage for this age group is one dose of 0.5mL.
.
Immunogenicity data obtained at 3 weeks after administration of Pandemrix (H1N1) or Arepanrix™ H1N1 in clinical studies in this age group suggest that a single dose may be sufficient.
.
If a second dose is administered, it should be given after an interval of at least three weeks. See section Pharmacodynamics.

Children and adolescents aged 10-17 years:
No clinical data are available for Arepanrix™ H1N1 in this age group. There are limited data available from a clinical study with Pandemrix™ (H1N1) in this age group.
.
The recommended dosage for this age group is in accordance with recommendations for adults.

Children aged from 6 months to 9 years:
One dose of 0.25mL (i.e. half of the adult dose) at an elected date.

Preliminary immunogenicity data obtained in a limited number of children aged 6-35 months who received two doses of 0.25 mL of Pandemrix™ (H1N1) containing 1.9 µg HA derived from A/California/7/2009 (H1N1) and a limited number of children aged 3-9 years who received one dose of 0.5 mL of Pandemrix™ (H1N1) show that a good immune response is elicited after the first dose, but there is a further immune response to a second dose of 0.25 mL administered to children aged 6-35 months after an interval of three weeks.

Extremely limited studies were done prior to getting interim approval from the Minister of Health. In some cases, they were using different vaccines and working with different strains. Not really an apples to apples comparison.

6. Inadequate Trials: (Monovalent Vaccine)

Elderly (>60 years):
No clinical data are available for Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. One dose of 0.5mL may be administered at an elected date.

Children and adolescents aged 10-17 years:
No clinical data are available for the Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. One dose of 0.5mL may be administered at an elected date.

Children aged 3-9 years:
No clinical data are available for the Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. The use of this vaccine should be considered in light of PHAC recommendations for the A/California/7/2009(H1N1)v-like vaccination. Preliminary data with other similar unadjuvanted vaccines suggest that if used in this age group, a 2-dose regimen (0.5mL with an interval of at least 21 days between doses) is recommended.

Children aged from 6-35 months:
No clinical data are available for the Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. The use of this vaccine should be considered in light of PHAC recommendations for the A/California/7/2009(H1N1)v-like vaccination. Preliminary data with other similar unadjuvanted vaccines suggest that for this age group, unadjuvanted vaccine may not be suitable against this pandemic strain.

Children aged less than 6 months:
Vaccination is not currently recommended in this age group.
For further information, see section Pharmacodynamics.

This isn’t selective editing or anything of the sort. Health Canada approved the use of this drug for children between 6 months and 17 years, and over the age of 60, without there being clinical data to support that it worked. This is chilling to read.

7. Approval Of Experimental Drugs

“The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment.” [from the Food and Drugs Act]

That is Section 30.1(1) of the Food and Drug Act of Canada. It was used to approve 2 vaccines without full and complete trials. They were:
[1] Arepanrix™ H1N1 (AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine)
[2] Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant)

The Minister has the discretion to do this. And it happened, despite there not being adequate testing done. Could the same thing happen with Covid-19?

8. Indemnification From The Courts

Adam, Abudu v. Ledesma-Cadhit et al, 2014 ONSC 5726 (CanLII)
Adam v. GlaxoSmithKline Inc., 2019 ONSC 7066 (CanLII)

There are actually 2 different rulings based on vaccine injury from GlaxoSmithKline. Here are quotes from the later ruling.

[15] In early 2009, the WHO became aware of the development of a new strain of influenza virus: H1N1, commonly known as swine flu. It had not been seen in human populations before, as a result of which humans had no built up immunity. The WHO declared H1N1 to be a pandemic.

[16] On June 11, 2009, the WHO declared a phase 6 pandemic. This is the final and most serious stage of a pandemic. It marks sustained human-to-human transmission of the virus in more than one region of the world. By early July there had been 94,512 reported cases and approximately 429 recorded deaths attributable to H1N1.

[17] In the summer of 2009, the WHO called for manufacturers to begin clinical trials for a vaccine to combat H1N1.

[18] GSK developed two vaccines to combat H1N1: Arepanrix and Pandemrix. Both are substantially similar. Pandemrix was manufactured and distributed in Europe. Arepanrix was manufactured and distributed in Canada. Clinical trials for Arepanrix began in 2008 but had not been completed when the pandemic was declared.

[19] The federal Minister of Health authorized the sale of the Arepanrix vaccine pursuant to an interim order dated October 13, 2009. Human trials of the vaccine were still underway. The Minister of Health is empowered to make interim orders if immediate action is required because of a danger to health, safety or the environment. In issuing the interim order, Health Canada deemed the risk profile of Arepanrix to be favourable for an interim order. The authorization was based on the risk caused by the current pandemic threat and its danger to human health. As part of the interim order process, Health Canada agreed to indemnify GSK for any claims brought against it in relation to the administration of the Arepanrix vaccine.

[20] Although human trials of Arepanrix were not finished by the time Health Canada authorized its use, the vaccine was not without clinical history.

[34] The plaintiffs’ principal allegation with respect to the standard of care is that GSK failed to make adequate disclosure of the risks involved with Arepanrix.

[35] The plaintiffs began their challenge about disclosure with the evidence of Ms. Hyacenth who testified that she was not told that: (i) the vaccine had not been tested through the usual route, (ii) the vaccine had been subject to a hastened approval process by Health Canada, (iii) adjuvants had never been used in children, (iv) the Government of Canada was indemnifying the vaccine manufacturer; and (v) some countries refused to make the vaccine available because of safety concerns. Ms. Hyacenth says that had she been told about these things she would not have risked having her children vaccinated.

[36] Part of the challenge of the plaintiffs’ inadequate disclosure case is that Ms. Hyacenth was not the direct purchaser of the vaccine. Vaccines are administered through a “learned intermediary,” in this case, her family physician. The issue is significant because any disclosures GSK makes are made in product monographs or inserts that accompany each vial of vaccine. The patient getting the vaccine does not receive the box containing the vaccine and whatever disclosure document it contains. It is the physician who receives this.

[37] GSK did disclose in its Product Information Leaflet for the Arepanrix vaccine and in its product monograph that Health Canada had authorized the sale of the vaccine based on only limited clinical testing and no clinical experience at all with children. Dr. Ledesma-Cadhit believes she knew this from the Health Canada website. She was also aware that Arepanrix was authorized through a special process because of the pandemic.

[38] The product monograph for Arepanrix disclosed that there was limited clinical experience with an investigational formulation of another adjuvanted vaccine but no clinical experience with children. In addition, the product information leaflet and product monograph disclosed a number of risks.

In short, Health Canada approved, or rather authorized, a vaccine that in which trials were still ongoing. The doctor, despite reading the lengthy disclaimer, injected it, and this comes in spite of there being no trials on children.

The Canadian Government had agreed to indemnify the manufacturer, GSK, ahead of time. Moreover, the victims didn’t buy the product from the manufacturer, but from the doctor, a “learned intermediary”. In short, GlaxoSmithKline was legally off the hook for what it sold to the public.

Can we expect the same sort of thing here with Covid-19? Will the Government approve a vaccine (or multiple vaccines), that haven’t properly been tested, and indemnify the manufacturers? After all, the patients aren’t buying directly from the manufacturer, but are getting it from their doctors.

Moreover, doctors are largely immune from action against them if they are following approved practices. In this case, it would be administering drugs that Health Canada approved.

GSK has been registered as lobbying the Federal Government since 1996, and there are hundreds of communications reports. But getting an indemnification agreement was probably just a coincidence.

9. Strange Events Happened In 2010

The next year, Tam would go on to have an appearance in the movie “Outbreak: Anatomy Of A Plague”. She advocated locking people up and putting tracking bracelets on them. Quite the bit of predictive programming.

Rockefeller.Foundation.lockstep.2010

The infamous “Lockstep Narrative” was also written in 2010. That was just one scenario laid out in the infamous paper, but it largely parallels what’s happening today.

10. History Repeating Itself In 2020?

This may seem a bit hyperbolic, but what is going on in 2009 with Swine Flu closely parallels what is happening Covid-19. Main points include:

-Neil Ferguson and Imperial College London
-Useless PCR tests to detect viral infection
-Vaccines not fully tested
-Health Canada approves despite incomplete tests
-Vaccine manufacturers are indemnified

There are some differences though. The World Economic Forum wasn’t touting the “Great Reset”, and communist movements weren’t nearly as overt as today. Or perhaps that was all just setting it in motion.

Posted on

Green New Deal Group, Taking Lessons From The 2008 Banking Bailout

Think recent public efforts to convince the public to act on climate change just happened? No, they are the result of years of planning, and from an organization called Green New Deal Group.

There is some real strategy at play here. Divert people’s attention with protests, riots, and public movements, and the agenda can be quietly passed. After all, how much coverage do the various treaties we sign (and bills we pass), actually get?

1. About Green New Deal Group

As in past times of crises, disparate groups have come together to propose a new solution to an epochal challenge. The Green New Deal Group drew inspiration from the ambition of President Roosevelt’s comprehensive response to the Great Depression to propose a modernised version, a ‘Green New Deal’ in 2008. It was designed to kick start a rapid transition to a new economy shaped to prevent a climate breakdown and transform a failed financial system. The Green New Deal will power a renewables revolution, create thousands of green-collar jobs across the economy and rein in the distorting and socially-destructive power of the finance sector while making more low-cost capital available for pressing priorities.

Meeting since early 2007, the membership of the Green New Deal Group is drawn to reflect a wide range of expertise relating politics and economics, and the climate, nature and inequality crises. The views and recommendations of the Green New Deal series of reports, are those of the group writing in their individual capacities.

The Green New Deal Group is, in alphabetical order:
.
Larry Elliott, Economics Editor of the Guardian, Colin Hines, Co-Director of Finance for the Future, former head of Greenpeace International’s Economics Unit, Jeremy Leggett, founder and Chairman of Solarcentury and SolarAid, Clive Lewis, Labour MP, Caroline Lucas, Green Party MP, Richard Murphy, Professor of Practice, City University, Director Tax Research LLP, Ann Pettifor, Director, Policy Research in Macroeconomics (PRIME), Charles Secrett, Advisor on Sustainable Development, former Director of Friends of the Earth, Andrew Simms, Co-Director, New Weather Institute, Coordinator, The Rapid Transition Alliance, Assistant Director, Scientists for Global Responsibility. Geoff Tily Senior Economist, TUC

Those are the people who make up the Green New Deal Group. In essence, this is the brainchild behind the eco movement in recent years.

2. GNDG Used To Reboot After 2008 Crash

In the coverage of the causes and likely future effects of the credit crunch, such grim parallels are becoming commonplace. But it’s now time to move from problems to solutions, and here too the Depression can form a useful reference point. Franklin Roosevelt’s action programme for dealing with the aftermath of the late 1920s credit crunch was threefold: first, strictly regulate the cause of the problem – the greedy and feckless finance sector; second, get people back to work, and generate business opportunities by a New Deal. This invested billions of dollars in training, better working conditions and a huge range of infrastructural projects such as highways, dams and bridges. Finally, fund this in part by an increase in taxes on big business and the rich – a measure which also had the positive effect of dramatically decreasing inequality.

Today the re-regulation of finance is even being discussed among consenting free market adults in the columns of the Financial Times. My colleague, environmentalist Colin Hines, has fleshed out the details of a Green New Deal which could help re-boot the economy after the credit crash, while putting serious money into addressing climate change.

As a result of the 2008 crash, this group decided that it would make a great opportunity to completely remake their economy, and deal with climate change in the first place. They reasoned that if banks were worth pouring trillions into, then the environment must be as well. The argument does have some merit to it.

Notice that it’s compared to the “New Deal” that Franklin Delano Roosevelt launched in the 1930s. This is not the last time that comparison will come up.

Alexandria Ocasio-Cortez introduced the U.S. public to the Green New Deal in 2019, just after taking office. It wasn’t some brainstorm she had, but had been drawn up many years ago. The YouTuber, Mr. Reagan, did address that AOC was a puppet, but he missed how far back the plan went.

3. GND Group To Solve “Triple Crunch”

Can I trust the bank to look after my money? Clickety clack. How much has my house fallen in value? Clickety clack. Will high fuel prices mean I can’t keep my car on the road? Can I afford to buy enough food for the family? Clickety clack. Will I lose my job, and why is everyone making me paranoid about climate change when there’s nothing I can do about it? Clickety, clickety clack … and then back to the beginning. The “triple crunch” of a credit-fuelled financial crisis, accelerating climate change and soaring energy prices – how did we get into this mess? In the face of so many simultaneous crises, we all have legitimate questions for the governments that allowed us to sleepwalk into this situation.

The Green New Deal was dreamed up as a way to solve multiple problems, such as: (a) financial crisis; (b) climate change; and (c) energy prices all at once.

While it’s nice to see the financial crisis addressed, this group seems to miss the elephant in the room: central banking. It’s that the Government legislates in such a way that the U.S. is forced to borrow — at interest — from the Federal Reserve, a private organization. Do they not know about any of this?

4. History Of The Green New Deal

Where the Green New Deal came from
.
The idea of a Green New Deal first arose at the time of 2007-2008 financial crisis roughly simultaneously in the us and the UK. New York Times columnist Thomas Friedman wrote an article in January 2007 that suggested the approach. The same year the UK-based Green New Deal group formed, independently developing and publishing the first full proposal for a Green New Deal in July 2008. The group’s report laid out the architecture of the Green New Deal for the first time: combining reining in the power of big finance and transforming the way that government manages the economy with a plan to transform the economy and society to meet the challenges of climate change. The group also published several subsequent reports developing the idea over the following years. The Green New Deal was then taken up by the Green Party in the UK, by Green parties across Europe and by the United Nations Environment Programme. In 2018, the idea was revived by us senator Alexandria Ocasio-Cortez and the Sunrise Movement in the US following a meeting between a member of her team and UK Green New Deal group member Ann Pettifor. When AOC published a bill for the Green New Deal with Senator Edward Markey in February 2019 the idea caught on around the world.

Far from being some sort of a revolutionary, AOC was simply the latest person assigned to run with the agenda. While it is easy to mock the GND outright, it seems that elements of it are embedded within Agenda 2030 and the Great Reset.

5. UK PM Gordon Brown Promotes GND

Moving the UK to a low-carbon economy will create 400,000 new jobs over the next eight years, Gordon Brown has told a summit in London.
.
The prime minister called for an international “green new deal” to boost the environmental sector and help lift the global economy out of recession.
.
This will increase “confidence and certainty”, he added.
.
But unions and environmental groups called for more funding for green projects, along with better regulation.
The government has set a target of reducing greenhouse gas emissions by 80% from 1990 levels by 2050.

When he was Prime Minister of the UK, Gordon Brown openly called for a “Green New Deal” to rebuild the country after the banking collapse.

6. Green Quantitative Easing

As the Bank of England moves closer towards announcing an unprecedented third round of ‘Quantitative Easing’, experts are calling for this newly created money to be used more productively and effectively to achieve key social and environmental objectives. During the last round of Quantitative Easing (’QE’) the Bank of England purchased £275bn worth of government bonds with money it newly created. As the Bank of England prepares the ground to inject a likely £50bn to £75bn into the economy, the UK’s Green Party MP, Caroline Lucas, and Southampton University banking expert Professor Richard Werner, are calling for this money injection to be used for green projects that directly improve the environment and long-term quality of life, while creating many new jobs. Said Professor Richard A. Werner, Director of the Centre for Banking, Finance and Sustainable Development at the University of Southampton: “Many people would like money creation to be used to help the wider economy directly and to implement some badly needed green projects that would enhance the sustainability of the economy and improve the environment—as well as create new jobs.”

Green Quantitative Easing Paper

In 2012, Richard Werner submitted a proposal for “green quantitative easing”. In short, it would still involve printing off large sums of money. However, it would be spent on environmental causes, instead of being poured into banks.

7. GND Group UK Budget Submission

A Green New Deal Group briefing, The Green New Deal: Securing the Future, was sent to the Chancellor ahead of the March 2020 budget, with a letter signed by MPs from all the main opposition parties.

As the briefing, written by Green New Deal Group member Richard Murphy sets out, the Green New Deal Group have long argued that it is prudent for government to borrow (by issuing bonds) to invest in the transformation of our infrastructure and businesses while interest rates are low. The briefing shows how such government borrowing could be financed in a way that also creates a safe place for the nation’s pensions and savings, by making simple changes to existing tax incentives. Much of the £70bn saved annually in ISAs could then be invested in government-backed green bonds at an interest rate of 1.85% (the UK government’s current average cost of borrowing) and a quarter of the £100bn currently invested in pensions could be directed into Green New Deal investment.

A budget proposal was submitted to the UK Government in March 2020. It was written by the Green New Deal Group, and was able to get the signatures of many politicians.

8. Protests/Riots Partly Entirely For Show

In recent years, there have been loud environmental movements going on across the Western World. There have been efforts to shut down industries, pipelines, and society altogether. These people seem oblivious to the fact that shutting down oil (for example), would lead to a drastic reduction in their living standards.

However, this is a sleight of hand. Even though politicians appear to be turned off by the antics of violent protesters, they work behind the scenes to ensure that the goals are enacted anyway. Treaties such as Agenda 21, Agenda 2030, and the Great Reset are designed to achieve many of the same goals.

BOLD Like A Leopard wrote a great piece on some of the forces acting behind the scenes. It’s well worth the time to read.

Now we look at the bigger picture. While the public is distracted by very visible protests over environmental issues, just quietly implement them behind the scenes. People likely won’t notice. They are too focused on radicals who seem hell bent on destabilization, though those are distractions.

9. Bankers Run Climate Change Movement

This will seem a cruel twist, but central banks are heavily behind the green movement. One such group is the Network for Greening the Financial System, which currently boasts 75 members.

Hard to be part of the resistance when the financial sector supports, (or at least appears to support), green initiatives. It’s unclear, however, if the banks simply co-opted the movement, or whether they were always running things from behind the scenes.

Green New Deal Group Main Page
https://archive.is/ncRvA
WayBack Machine Archives

About Us: Green New Deal Group
https://archive.is/rxRpv
WayBack Machine Archive

https://greennewdealgroup.org/2008/04/
Guardian 2008: We Wanted A Green New Deal
https://greennewdealgroup.org/2008/07/
Guardian 2008 Article On The Triple Crunch
https://greennewdealgroup.org/2009/03/
Gordon Brown Calls For Global Green New Deal
https://greennewdealgroup.org/2009/07/
The Ecologist: Bailed Out Banks Should Fund GND
Green New Deal Group Budget Proposal
Network For Greening The Financial System

AOC: This Is Our World War II
Mr. Reagan: The Brains Behind AOC
NBC On Sunrise Movement

Posted on

CV #24(B): London School Of Hygiene & Tropical Medicine, More Modelling Financed By Gates

The London School Of Hygiene & Tropical Medicine gets substantial funding from the Bill & Melinda Gates Foundation, as does Imperial College London. And both have been funded to conduct computer modelling. Let’s dive in a bit deeper.

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes. The Gates Foundation finances many things, including, the World Health Organization, the Center for Disease Control, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the British Broadcasting Corporation, Sick Kids Hospital, and individual pharmaceutical companies. Worth mentioning: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations (IHR), that the WHO imposes are legally binding on all members.

2. Tax Filings Of B&M Gates Foundation

(Note: these are just a portion of the 2018 filings)

BILL & MELINDA GATES FOUNDATION
EIN: 56-2618866
gates.foundation.taxes.2016
gates.foundation.taxes.2017
gates.foundation.taxes.2018

3. Still Getting Money For Modelling

London School of Hygiene and Tropical Medicine
Date: September 2020
Purpose: to model the direct and indirect health and economic impacts of COVID-19 in LMICs
Amount: $166,059
Term: 11
Topic: Delivery of Solutions to Improve Global Health
Program: Global Development
Grantee Location: London
Grantee Website: http://www.lshtm.ac.uk/

Granted, the School of Hygiene and Tropical Medicine isn’t nearly as notorious as Imperial College London is at this point. However, Gates is still paying for computer modelling, so one has to wonder if the results are preplanned.

4. Earlier Gates Money For Modelling

London School of Hygiene and Tropical Medicine
Date: October 2016
Purpose: to maximize impact and accelerate development of new TB vaccines by creating and applying novel mathematical models to estimate the main target product profiles drivers for epidemiological impact of new TB vaccines
Amount: $193,437
Term: 39
Topic: Tuberculosis
Program: Global Health
Grantee Location: London
Grantee Website: http://www.lshtm.ac.uk/

The Gates Foundation also donated to some 2016 computer modelling. There are of course other grants over the years.

5. Centre for the Modelling of Infectious Diseases

The Centre for the Mathematical Modelling of Infectious Diseases (CMMID) at the London School of Hygiene & Tropical Medicine is a multidisciplinary grouping of epidemiologists, mathematicians, economists, statisticians and clinicians from across all three faculties of LSHTM.

That is the main team of researchers who are involved in the computer modelling (or guesswork), trying to determine how much viruses will spread.

6. Online Course: Intro To Modelling

Infectious diseases remain a leading cause of morbidity and mortality worldwide, with HIV, tuberculosis and malaria estimated to cause 10% of all deaths each year. New pathogens continue to emerge, as demonstrated by the SARS epidemic in 2003, the swine flu pandemic in 2009, MERS CoV in 2013, Zika in 2016 and recently, SARS-CoV-2.

Mathematical models are being increasingly used to understand the transmission of infections and to evaluate the potential impact of control programmes in reducing morbidity and mortality. Applications include determining optimal control strategies against new or emergent infections, such as SARS-CoV-2, Zika or Ebola, or against HIV, tuberculosis and malaria, and predicting the impact of vaccination strategies against common infections such as measles and rubella. Modelling was used extensively in the UK during the recent swine flu pandemic to monitor the extent of ongoing transmission and the potential impact of control such as school closures and vaccination. It is currently being used in many countries to predict the impact of interventions against COVID-19.

This two week online course, organised jointly between the London School of Hygiene & Tropical Medicine and Public Health England is intended to introduce professionals working on infectious diseases in either developing or developed countries to this exciting and expanding area. The emphasis will be on developing a conceptual understanding of the basic methods and on their practical application, rather than the manipulation of mathematical equations. The methods will be illustrated by “hands-on” experience of setting up models in spreadsheets as well as other specialist modelling packages, and seminars in which the applications of modelling will be discussed.

If you have 1,700 pounds to spare, then this modelling course may be for you. It’s an introduction into how computer modelling works to estimate growth and decay.

While it is true that computer modelling was used in Zika, Ebola and Swine Flu, that’s not really something to brag about. Just search “Neil Ferguson Imperial College London”.

The focus won’t be on manipulating mathematical equations? That’s good I guess.

7. Gates Very Well Known In LSHTM

A quick search of Bill Gates on the school’s website flags 143 articles. Gates, and his foundation, are well known and written about.

8. Models Aren’t Evidence Of Anything

This should be abundantly clear to all, but it is worth repeating. Models are just predictions, and limited by:

[1] The quality of the data coming in
[2] The understanding of how nature actually works
[3] The political agenda of the modeler

They are not proof or evidence, and should be given no weight when it comes to making complicated and expensive policy decisions.

We see time and time again that the information going in is garbage, and that the people doing the work have little to no grasp of what they are estimating. We also see too many politicians, bureaucrats, academics, and people in business who have their own agenda.

Don’t take any of these “predictions” at face value.

Posted on

CV #1: Coronavirus Patent By Pirbright Institute, Funded By Gates Foundation

1. Important Links

(1) https://canucklaw.ca/cv-0-corona-plandemic-lobbying-deleted-resources-cl-listings-theresa-tam-canadas-hoaxer-zero
(2) https://patents.justia.com/patent/10130701
(3) http://archive.is/n6Glh
(4) https://patents.justia.com/assignee/the-pirbright-institute
(5) http://archive.is/ta93g
(6) https://www.pirbright.ac.uk/
(7) http://archive.is/GqAiL
(8) https://www.pirbright.ac.uk/our-science/avian-viral-diseases/coronaviruses
(9) http://archive.is/btkMI
(10) https://www.pirbright.ac.uk/news/2019/11/bill-melinda-gates-foundation-funds-development-pirbright’s-livestock-antibody-hub
(11) http://archive.is/WbdNH
(12) https://www.pirbright.ac.uk/news/2020/01/pirbright’s-livestock-coronavirus-research-–-your-questions-answered
(13) http://archive.is/knC79
(14) https://www.businessinsider.com/scientist-simulated-coronavirus-pandemic-deaths-2020-1
(15) http://archive.is/KJGpl
(16) https://www.telegraph.co.uk/science/2017/04/19/bill-gates-terrorists-could-wipe-30-million-people-weaponising/
(17) http://archive.is/m2wGl
(18) https://www.cbc.ca/news/canada/manitoba/chinese-researcher-escorted-from-infectious-disease-lab-amid-rcmp-investigation-1.5211567
(19) http://archive.is/MeAfB
(20) https://www.cbc.ca/news/canada/winnipeg-researcher-charged-with-smuggling-ebola-material-into-u-s-1.774725
(21) http://archive.is/tdZTK

2. Check Out Civilian Intelligence Network

Another Canadian researcher worth a close look on this subject.

https://civilianintelligencenetwork.ca/2020/01/25/the-canary-is-dead-wuhan-coronavirus-launches-global-depopulation-plan/

https://civilianintelligencenetwork.ca/2020/01/27/bill-gates-the-coronavirus-conspiracy/

https://civilianintelligencenetwork.ca/2020/01/26/un-plans-to-blackmail-countries-for-coronavirus-vaccine/

There is tons of information on these 3 articles. Rather than rehashing or recreating what they have, here are the links to look for yourself.

3. Coronavirus Patent Application in 2015 (Pirbright)

This may come across as a conspiracy theory (and it sounds like one), but let’s take a look into the patent that Pirbright Institute recently obtained.

Patent History
Patent number: 10130701
Type: Grant
Filed: Jul 23, 2015
Date of Patent: Nov 20, 2018
Patent Publication Number: 20170216427
Assignee: THE PIRBRIGHT INSTITUTE (Woking, Pirbright)
Inventors: Erica Bickerton (Woking), Sarah Keep (Woking), Paul Britton (Woking)
Primary Examiner: Bao Q Li
Application Number: 15/328,179

Classifications
Current U.S. Class: Coronaviridae (e.g., Neonatal Calf Diarrhea Virus, Feline Infectious Peritonitis Virus, Canine Coronavirus, Etc.) (424/221.1)
International Classification: A61K 39/215 (20060101); C12N 7/00 (20060101); C12N 9/12 (20060101); A61K 39/00 (20060101);

Coronavirus
Jul 23, 2015 – THE PIRBRIGHT INSTITUTE
The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

Description
FIELD OF THE INVENTION
The present invention relates to an attenuated coronavirus comprising a variant replicase gene, which causes the virus to have reduced pathogenicity. The present invention also relates to the use of such a coronavirus in a vaccine to prevent and/or treat a disease.

Coronaviruses are divided into four groups, as shown below:
.
Alpha
Canine coronavirus (CCoV)
Feline coronavirus (FeCoV)
Human coronavirus 229E (HCoV-229E)
Porcine epidemic diarrhoea virus (PEDV)
Transmissible gastroenteritis virus (TGEV)
Human Coronavirus NL63 (NL or New Haven)
.
Beta
Bovine coronavirus (BCoV)
Canine respiratory coronavirus (CRCoV)—Common in SE Asia and Micronesia
Human coronavirus OC43 (HCoV-OC43)
Mouse hepatitis virus (MHV)
Porcine haemagglutinating encephalomyelitis virus (HEV)
Rat coronavirus (Roy). Rat Coronavirus is quite prevalent in Eastern Australia where, as of March/April 2008, it has been found among native and feral rodent colonies.
(No common name as of yet) (HCoV-HKU1)
 Severe acute respiratory syndrome coronavirus (SARS-CoV)
Middle East respiratory syndrome coronavirus (MERS-CoV)
.
Gamma
Infectious bronchitis virus (IBV)
Turkey coronavirus (Bluecomb disease virus)
Pheasant coronavirus
Guinea fowl coronavirus
.
Delta
Bulbul coronavirus (BuCoV)
Thrush coronavirus (ThCoV)
Munia coronavirus (MuCoV)
Porcine coronavirus (PorCov) HKU15

More information is available here, but the point is this: the coronaviruses were (allegedly) modified to help cure other diseases, such as bronchitis.

The variant replicase gene of the coronavirus of the present invention may be derived from an alphacoronavirus such as TGEV; a betacoronavirus such as MHV; or a gammacoronavirus such as IBV.

As used herein the term “derived from” means that the replicase gene comprises substantially the same nucleotide sequence as the wild-type replicase gene of the relevant coronavirus. For example, the variant replicase gene of the present invention may have up to 80%, 85%, 90%, 95%, 98% or 99% identity with the wild type replicase sequence. The variant coronavirus replicase gene encodes a protein comprising a mutation in one or more of non-structural protein (nsp)-10, nsp-14, nsp-15 or nsp-16 when compared to the wild-type sequence of the non-structural protein.

This new version is apparently a derivative of an alpha, beta, or gamma coronavirus already in existence. I’ve been told this Wuhan coronavirus has nothing to do with Pirbright’s patent or work. Although the patent information states that the patented version may contain 80-99% of the wildtype replicase sequence.

The variant is essentially a mutation in 1 (or more) non-structural proteins.

Still, one heck of a coincidence to be doing so much research into a specific area and then something else emerges. It will become apparent why soon.

4. Pirbright Institute’s Other Patents

Attenuated African swine fever virus vaccine
Patent number: 10507237
Abstract: The present invention provides an attenuated African Swine Fever (ASF) virus which lacks a functional version of the following genes: multigene-family 360 genes 9L, 10L, 11L, 12L, 13L and 14L; and multigene-family 505 genes 1R, 2R, 3R and 4R. The invention further provides an attenuated African Swine Fever (ASF) virus which lacks a functional version of the DP148R gene. The present invention also provides a vaccine comprising such an attenuated virus and its use to prevent ASF. Further, the invention relates to intranasal administration of an attenuated ASF virus.
Type: Grant
Filed: June 19, 2015
Date of Patent: December 17, 2019
Assignee: The Pirbright Institute
Inventors: Charles Abrams, Ana-Luisa Reis, Chris Netherton, Linda Dixon, Dave Chapman, Pedro Sanchez-Cordon

Stabilised FMDV capsids
Patent number: 10294277
Abstract: The present invention relates to the stabilization of foot-and-mouth disease virus (FMDV) capsids, by specific substitution of amino acids in a specific region of FMDV VP2. The invention provides stabilized FMDV capsids and vaccines against FMD.
Type: Grant
Filed: March 25, 2014
Date of Patent: May 21, 2019
Assignee: The Pirbright Institute
Inventors: Abhay Kotecha, David Stuart, Elizabeth Fry, Robert Esnouf

Stabilised FMDV Capsids
Publication number: 20190135874
Abstract: The present invention relates to the stabilisation of foot-and-mouth disease virus (FMDV) capsids, by specific substitution of amino acids in a specific region of FMDV VP2. The invention provides stabilised FMDV capsids and vaccines against FMD.
Type: Application
Filed: January 17, 2019
Publication date: May 9, 2019
Applicant: Pirbright Institute
Inventors: Abhay Kotecha, David Stuart, Elizabeth Fry, Robert Esnouf

Chicken cells for improved virus production
Patent number: 10202578
Abstract: The present Invention provides as avian cell in which the expression or activity of one or more of the following genes, or a homologue thereof: Chicken IFITM 1 (SEQ ID No. 1); Chicken IFITM2 (SEQ ID No. 2) and Chicken IFITM3 (SEQ ID No. 3) is reduced. The invention also provides methods for passaging viruses in avian cells, embryos and/or avian cell lines which have reduced expression of one or more IFITM genes and methods which involve investigating the sequence of one or more of the following genes, or a homologue thereof: Chicken IFITM1 (SEQ ID No. 1); Chicken IFITM2 (SEQ ID No. 2) and Chicken IFITM3 (SEQ ID No. 3).
Type: Grant
Filed: June 3, 2014
Date of Patent: February 12, 2019
Assignee: THE PIRBRIGHT INSTITUTE
Inventors: Mark Fife, Mark Gibson

That is just a few patents that The Pirbright Institute has. Now it seems harmless enough. But what happens if or when one of their creations becomes weaponized and turned against the public?

5. Gates Foundation Finances Pirbright Inst.

Researchers from The Pirbright Institute have been awarded US $5.5 million by the Bill & Melinda Gates Foundation to establish a Livestock Antibody Hub aimed at improving animal and human health globally. The ambitious programme of work will see extensive collaboration between multiple UK research organisations in order to utilise research outcomes in livestock disease and immunology to support human health as part of the ‘One Health’ agenda.
Six leading scientists from Pirbright will be involved in the project, including Professor John Hammond, Professor Venugopal Nair, Dr Simon Graham, Dr Elma Tchilian, Professor Munir Iqbal and Dr Erica Bickerton. Their combined expert knowledge will drive the study of cattle, pig and poultry antibody responses at high resolution to expand our understanding of protective immunity in species that can also be used as models for a range of human infectious diseases.

The aim is to use Pirbright’s expertise in livestock viral diseases, cutting-edge technology and unique high-containment facilities to bring antibody discovery, manipulation and testing up to the benchmark already seen in the immunological field for rodents and humans. “New tools have given us the opportunity to utilise these detailed antibody responses to make the next generation of vaccines and therapies” said research lead Professor Hammond.
This highly collaborative work will address the needs of the livestock research community whilst bridging the requirements of the vaccine industry. A number of work programmes will focus on studying B cells and antibodies at multiple scales including gene expression, single cell function and the entire antibody response.

Findings from this research will be used to drive vaccine selection and design and test antibody therapies, “which will improve animal health and ultimately human health, as well as ensuring the security of our food supply”, finished Professor Hammond. Pirbright will ultimately act as a ‘Hub’ able to provide specific methods, access to animal models and the associated expertise to drive antibody research within the ‘One Health’ agenda.

“This is the single biggest investment in the immunology of livestock in the UK from an international funder, and the British Society for Immunology will do all we can to support this collaborative initiative and help maximise its impact for the benefit of human and animal health”, commented Dr Doug Brown, Chief Executive of the British Society for Immunology

A major contributor to Pirbright Institute is the Gates Foundation, headed by Bill and Melinda Gates. Yes, those Gates. But why is that an issue? What’s wrong with a wealthy couple contributing to help prevent infectious diseases?

Let’s put it this way: Bill Gates has some views that are (mildly) controversial. He has gone on record with comments that suggest be supports human depopulation — reducing the number of people on Earth. Could this be a way to accomplish that goal?

6. Cull The Population To Save Planet?

(Bill Gates and depopulation, from 2011, clip from video)
https://www.youtube.com/watch?v=Gc16H3uHKOA

(Bill Gates and depopulation, from 2011, entire video)
https://www.youtube.com/watch?v=-WFa4bHC0Do

(Bill Gates, improved health care, overpopulation)

(Bill Gates: health and population correlation)

(Bill Gates: vaccines and Ebola virus)

Yes, Gates flouts the sales pitch that improving health results in less population. His stated reasoning is that people will simply have less children if they know the kids are more likely to survive into adulthood.

Problem is, that hasn’t fared out. Look at Africa and the Middle East. Improvements in health have lead to an exploding population. Granted, their goal (those who are Muslim) is to outbreed and eventually overrun every nation on Earth. But the population drop Gates claims simply isn’t a reality.

Now, is this simply an attitude that Bill Gates has, or has he taken any steps to estimate how the population could be reduced? Instead of lowering birth rates, perhaps there is a simpler and more direct method.

7. Bill Gates Running “Death Scenario”

A viral pandemic could kill 65 million people
Toner’s simulation imagined a fictional virus called CAPS. The analysis, part of a collaboration with the World Economic Forum and the Bill and Melinda Gates Foundation, looked at what would happen if a pandemic originated in Brazil’s pig farms. (The Wuhan virus originated in a seafood market that sold live animals.)

The virus in Toner’s simulation would be resistant to any modern vaccine. It would be deadlier than SARS, but about as easy to catch as the flu.

The pretend outbreak started small: Farmers began coming down with symptoms that resembled the flu or pneumonia. From there, the virus spread to crowded and impoverished urban neighborhoods in South America.

Flights were canceled, and travel bookings dipped by 45%. People disseminated false information on social media.

After six months, the virus had spread around the globe. A year later, it had killed 65 million people.

Sure, this is all just a simulation. It’s just an academic exercise.

Of course, for people like Bill Gates, who claim that Carbon Dioxide has to be cut to save the planet, one has to wonder what his actual goals are. As outlined extensively in the CLIMATE CHANGE SCAM series, Carbon Dioxide isn’t pollution. This whole “industry” is very much a cash grab.

CLICK HERE, for Part II, the Paris Accord.
CLICK HERE, for Part III, Saskatchewan Appeals Court Reference.
CLICK HERE, for Part IV, Controlled Opposition to Carbon Tax.
CLICK HERE, for Part V, UN New Development Funding.
CLICK HERE, for Part VI, Disruptive Innovation Framework.
CLICK HERE, for Part VII, Blaming Arson On Climate Change.
CLICK HERE, for Part VIII, Review Of Green New Deal.
CLICK HERE, for Part VIII(II), Sunrise Movement & Green New Deal.
CLICK HERE, for Part IX, Propaganda Techniques, Max Boykoff.
CLICK HERE, for Part X, GG Pollution Pricing Act & Bill C-97.
CLICK HERE, for Part XI, Dr. Shiva Ayyadurai’s explanation of CCS.
CLICK HERE, for Part XII, Joel Wood and Carbon tax “option”.
CLICK HERE, for Part XIII, controlled opposition going to SCC.
CLICK HERE, for Part XIV, Mark Carney’s new UN role.
CLICK HERE, for Part XIV(II), Carney, CCX, Goldman, Central Banking.
CLICK HERE, for UN global taxation efforts.

So why is Gates pushing an obviously false narrative? Why claim that improving the health of people in Africa and the Middle East will result in a reduced birthrate and lower population? Why claim that Carbon Dioxide is a pollution that will harm the planet?

Is it just a coincidence this “simulation” happened just months before the real thing? Or was this a calculated test run?

8. CBC: Nothing To See Here, People

Public Health Agency of Canada describes it as a possible ‘policy breach,’ no risk to Canadian public

Sure, just a policy breach. Just some minor bureaucratic error that went on. Surely nothing that the peons have to concern themselves with.

“All of this is unproven, but even microbiology, sometimes especially microbiology, can have issues that involve national security.”

It’s something the Canadian Security Intelligence Service has already warned about, said Leah West, who teaches national security law at Carleton’s Norman Paterson School of International Affairs.

“Canada is facing threats from foreign governments seeking to steal intellectual property and that could include state-funded research,” she said.

“The two big things I want to see is whether or not these individuals are charged with crimes by the RCMP …that will give us a lot of information about what is really at stake here.”

West is also interested in seeing how this plays out politically between Canada and the Chinese government.

Sure there’s nothing to worry about. China is a hostile country who kidnapped 2 of our citizens after we locked up one of their spies (Meng). But why should this, or anything else, prohibit the Chinese from getting such clearance into Canadian facilities?

Let’s be clear: diversity is a lie. The vast majority of people’s strongest ties are with those who they share an ethnic (racial) bond with. Letting Chinese nationals into confidential Canadian labs under the guise of “cooperation and diversity”, is coming national suicide.

One has to wonder if the Canadian Government is really trying to kill us with what they allow to happen

9. Depopulation The Real Goal?

This could all be an extremely wild and unlikely coincidence, but it’s difficult to take on the surface. Too much money at stake, and other nations have an agenda.

For people who (claim to) believe that there are too many people on the planet, and that climate change is inevitable, we must ask a question: what would they be willing to do to stop it?

Is potentially killing millions (or billions) of people a way to save the planet by cutting emissions? Even though the climate change scam is based on lies? There is more here than what the public is being told.

And while you’re at it, go check out Civilian Intelligence Network.

On a semi-serious ending, doesn’t the outbreak of Wuhan Coronavirus come across like this (fictional) movie series of Resident Evil?

Posted on

CANZUK — Erasing Canada’s Borders and Sovereignty

(CPC party convention in Halifax, 97%-3% vote in favour of partially erasing Canadian borders)

(Canzuk video on its website)

1. Offshoring, Globalization, Free Trade

(A) https://canucklaw.ca/free-trade-1-thoughts-on-potential-canada-china-free-trade-deal
(B) https://canucklaw.ca/free-trade-2-nafta-lawsuits-sovereignty-massive-job-losses-conflict-of-interest/
(C) https://canucklaw.ca/free-trade-3-nafta-and-the-costs-its-supporters-ignore/
(D) https://canucklaw.ca/free-trade-4-the-trans-pacific-partnership-bill-c-79/
(E) https://canucklaw.ca/free-trade-5-why-trump-left-the-trans-pacific-partnership/

2. Important Links

(1) https://canucklaw.ca/imm-1-temporary-foreign-worker-program-other-migration
(2) https://canucklaw.ca/imm-2-close-to-1m-people-entering-canada-annually-excluding-tourists/
(3) https://www.canzukinternational.com
(4) http://archive.is/dsHPA
(5) https://canucklaw.ca/cpc-endorses-globalism-canzuk-birth-tourism-citizenship-for-refugees-islam/
(6) https://www.canzukinternational.com/2018/07/which-countries.html
(7) http://archive.is/vH7wu
(8) https://www.quora.com/How-many-countries-is-the-Queen-of-the-United-Kingdom-head-of
(9) http://archive.is/YXXxw
(10) https://www.canzuk.org/canzuk_defence_alliance_start_small_think_big.php
(11) http://archive.is/5fTxF

3. CANZUK’s Political Advisors

>

A lot of members of the “Conservative” Party of Canada. Have to wonder exactly what they’re “conserving” here. Also worth mentioning that Andrew Scheer, a “Conservative” also appears on the site with enthusiastic support for the agenda.

It was bad enough to see Scheer chugging a milk at his acceptance speech, (as his win was provided by Dairy Cartel rigging). This is arguably much worse. The erasure of Canada and Canadian borders marketed as opportunity.

4. CANZUK’s Official Mission

CANZUK International (CI) is the leading group advocating closer ties between Canada, Australia, New Zealand and the United Kingdom, known amongst diplomats at the United Nations as the ‘CANZUK Group’.

Free Trade
CANZUK International seeks to establish a comprehensive multi-lateral free trade agreement between Canada, Australia, New Zealand and the United Kingdom. Customs duties and other barriers to commerce would be removed. Such a union would give its constituent members more collective bargaining power in dealing with large trading partners such as the USA, China, India and the European Union.
.
Freedom of movement within the CANZUK Group for citizens of the four realms would be an essential ingredient for a successfully open market. As these nations have compatible economic profiles, this form of immigration would be unlikely to lead to distortions in labour markets. Not only would an arrangement of this kind make good economic sense, it would reinforce a feeling of solidarity amongst the four kindred peoples. The Trans-Tasman Travel Agreement between Australia and New Zealand is a working model upon which to build. Although freedom of movement exists for citizens of both countries, there is an exclusion provision for those deemed to be a threat to the national interest. In this way mobility can foster trade and economic growth without jeopardising security.

Foreign Policy
CANZUK International endeavours to promote greater cooperation amongst the CANZUK Group with respect to foreign policy, defence and intelligence gathering. The ‘Five Eyes’ (FVEY) agreement between Canada, Australia, New Zealand, the United Kingdom and the United States of America has been highly effective in gathering signals, military and human intelligence. It provides a useful starting point for a more comprehensive diplomatic alliance for the nations of the CANZUK Group, which would compliment the work of the North Atlantic Treaty Organisation (NATO) and the United Nations Security Council (UNSC). An association comprising Canada, Australia, New Zealand and the United Kingdom would enjoy a more balanced relationship with the United States. Collectively, these countries could be global rather than merely regional players in the geopolitical arena.

Constitutional Affairs
The shared Sovereign would be an essential aspect of any CANZUK Group association. The monarch, who represents a global institution, has played an important role as a symbol of a common heritage and parliamentary tradition. Furthermore, the Crown has been the cornerstone of democratic government and the rule of law over a long history of peaceful constitutional development. It is instructive to note that the English speaking countries which have retained the monarchy have been far more successful in avoiding civil unrest than their republican counterparts.
.
In concrete terms, the existing dialogue between viceregal representatives and the judiciary of the CANZUK Group should be encouraged. This initiative could build upon meetings that already occur between the Governors-General of the various Commonwealth realms every two years. The joint decision to revise the royal succession laws through the Perth Agreement of 2011 is a good example of effective collaboration in regard to matters of constitutional law.

One interesting thing is that this only talks about such closer cooperation between the “CANZUK” nations: Canada, New Zealand, Australia and the UK. A lot of this seems very reasonable.

However, in a different part of the website, CANZUK International talks about extending memberships far beyond the original 4 members. And it is quite a long list.

Remember: it is pitched to the general populations as increased cooperation between 4 nations of fairly similar language, culture and customs. That is how to sell it. Once it is sold and operational, the goal becomes to expand its size and influence.

Nice bait-and-switch.

5. CANZUK Could Expand To Other Countries

Using political, social and economic analysis, CANZUK International’s Research Associate, Luke Fortmann, explores the future possibilities of other countries joining a free movement and trade alliance with Canada, Australia, New Zealand and the United Kingdom.

It should be said that a new Commonwealth union would be welcoming of any potential members – with each being considered on a case-by-case basis – and that the CANZUK project is very much a work in progress; always receptive of fresh ideas and potential avenues to explore.

A useful way to begin is by taking a look at the CANZUK countries’ dependent territories, such as Christmas Island, the Cook Islands and Anguilla, for example, which are dependencies of Australia, New Zealand, and the UK, respectively, as well as the UK’s Crown dependencies (Guernsey, Jersey, and the Isle of Man).

Each area would naturally become full members of the new group along with the nations to which they are related. Some advocates claim that these small islands, and their generally sparse populations, are currently under-utilised, and that a CANZUK alliance would offer a tremendous opportunity for their communities to acquire a far more extensive set of rights by becoming equal partners in a union, while shaking off their somewhat colonial tint.

Widening our scope, we arrive at the Commonwealth realms. These realms are sovereign states who are members of the Commonwealth and who currently share Queen Elizabeth II as their monarch, of which, there are 16 including the CANZUK countries.

But, whether founded or not, the notion that free immigration was causing problems for the UK was undoubtedly a primary motivation for its departure from the European Union. A CANZUK union would seek to avoid such issues by moving slowly and steadily with the original four members, providing economic assistance to the realms before allowing their eventual membership.

Additionally, it’s been noted that, particularly concerning the more populous realms such as Jamaica and Papua New Guinea, immediate free movement would generate a rush of emigrants who may be poorly equipped for employment in the CANZUK countries; while at the same time enticing the more skilled minority away from their homeland in search of better-paying positions in the richer nations, ridding schools and hospitals of vital staff.

Instinctively, the next place to turn is to the Commonwealth as a whole. Broadening our vision in this way does present some of the same issues, as well as some new ones. A complete Commonwealth union would of course be dominated by India, with a population of over 1.3 billion, along with Pakistan (193 million), Nigeria (186 million), and Bangladesh (163 million) who would dwarf the CANZUK countries in terms of inhabitants, rendering them merely minor players.

When weighing up the potential barriers to entry that many of these Commonwealth countries have, we’re often confronted with the challenge that this new alliance is concerned only with nations that are populated by white folk. Such criticism is fairly lazy and can be easily dealt with. Firstly, as we’ve just seen, there’s absolutely no reason why these countries couldn’t join in the future, so long as efforts were directed at bringing them up to par in the ways just discussed.

At first, the project will be challenging enough, and caution will be required. Having said that, and as previously mentioned, CANZUK’s immense potential truly knows no bounds, and, down the line, further options can always be explored.

Theoretically, who could become part of CANZUK at some point in the future? Here is the list, based on the above criteria and comments:

  • Anguilla
  • Antigua
  • Australia
  • Bahamas
  • Bangladesh
  • Barbados
  • Belize
  • Canada
  • Christmas Island
  • Cook Islands
  • Grenada
  • Guernsey
  • India
  • Isle of Mann
  • Jamaica
  • Jersey
  • New Zealand
  • Nigeria
  • Pakistan
  • Papua New Guinea
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Solomon Island
  • Tuvalu
  • United Kingdom

Really? We were told this was an agreement between 4 first world, developed nations. Now we are bringing in half of the third world.

Let’s be clear: marketing with the 4 nations (Australia, Canada, New Zealand, and the UK) is just a sales pitch. The agreement could very well expand once this is in motion. And it likely will.

6. Possible CANZUK Joint Defense Force

The first objective of any government is to protect its own citizens from external danger. How can CANZUK help achieve that goal?

Australia, Canada, New Zealand and the United Kingdom have a common military heritage, and this shows in things as diverse as ranks, camouflage patterns and banners. They have a high degree of inter-operability – and in some cases, citizens of one nation can join the armed forces of another.

The nations have strategic similarities as well. Three out of four are island nations, whilst the fourth, Canada has the longest coastline of any nation. This places a premium on naval power – all the nations have considerable dependence on trade, vulnerability to blockades and an interest of open sea-lanes.

No joke. They are open about joint military and naval ventures. Interesting to note: aren’t this countries all part of NATO? How exactly would that square with those obligations, especially as Canada can’t afford to pay for its NATO commitments anyway?

To be fair, this soldier-swap already exists to a degree. The UK accepts Commonwealth citizens in its military. To a limited degree, Canada, Australia and New Zealand allow foreigners in as well. This seems a way to do it on a much bigger scale.

7. Where Is CANZUK Going?

CANZUK International was founded in January 2015 as The Commonwealth Freedom of Movement Organisation, and is the world’s leading non-profit organisation advocating freedom of movement, free trade and foreign policy coordination between Canada, Australia, New Zealand and the United Kingdom (the “CANZUK” countries).

Our campaign advocates closer cooperation between these four nations so they may build upon existing economic, diplomatic and institutional ties to forge a cohesive alliance of nation-states with a truly global outlook.

This seems harmless enough, but this will not be the end of it. The group will want to expand its sphere of influence and start controlling more issues and policies.

Remember, before the EU, there was a 6 nation bloc (France, West Germany, Italy, Luxembourg, Netherlands, Belgium). They started a trade agreement amongst themselves. Today, it is 28 nations — though the UK is leaving — and controls everything from budgets to agriculture to immigration. It swelled far beyond its original purpose.

It is very easy to see the “CANZUK 4” become 6, 8, 12, or 15. And those innocuous issues discussed on the website may morph into foreign bodies actually controlling national agendas.

As is obvious, the Conservative Party of Canada is an enthusiastic supporter of the CANZUK agenda. This is apparently regardless of the long-term erosion of national sovereignty. Globalists.